Ramipril 10 mg/Day Prevention
NCT01053910
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1012
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Interventions
DRUG:
Ramipril
Sponsor
Sanofi